What's happening
This bill requires insurance plans to fully reimburse healthcare providers for vaccine costs, administration, and related expenses.
Why it matters
Ensures providers are reimbursed not just for the vaccine itself, but also for associated costs. including shipping, handling, storage (at a mandated markup), supplies, data entry, counseling, inventory management, and routine nursing activities. This could encourage more providers to offer vaccinations and reduce financial barriers to stocking vaccines.
Aligns reimbursement rates with federal standards. by referencing the latest CDC private sector vaccine costs and Medicare rates for administrative expenses, creating consistency and potentially increasing transparency in how payment rates are set.
May improve vaccine access and equity. by making it more financially viable for smaller practices, rural clinics, and pharmacies to provide vaccines, which could help close gaps in vaccination rates among underserved populations.
Could impact insurance premiums and healthcare costs. by requiring insurers to cover a broader set of expenses related to vaccination, potentially leading to higher administrative costs for insurers but possibly lower out-of-pocket costs for patients and higher immunization rates overall.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Require Vaccine Cost Reimbursement
Plain English, a few words. Used as the page title.
Sponsors
Senator · Senate District 42
No co-sponsors yet.
History
- Referred to insurance
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Require Vaccine Cost Reimbursement
In Assembly Committee · Insurance · Sponsor Jeffrey Dinowitz
Full text
3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
6603
2023-2024 Regular Sessions
IN SENATE
April 28, 2023
Introduced by Sen. SKOUFIS -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance
AN ACT to amend the insurance law, in relation to insurance reimbursement for vaccination
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Clause (iii) of subparagraph (B) of paragraph 17 of subsection (i) of section 3216 of the insurance law, as amended by chapter 219 of the laws of 2011, is amended to read as follows:
(iii) necessary immunizations, as determined by the superintendent in consultation with the commissioner of health, consisting of at least adequate dosages of vaccine against diphtheria, pertussis, tetanus, polio, measles, rubella, mumps, haemophilus influenzae type b and hepatitis b, which meet the standards approved by the United States public health service for such biological products, including reimbursement to the health care provider for the acquisition costs of the vaccine, according to the current or most recently reported United States centers for disease control and prevention private sector cost plus a minimum of twenty-one percent for shipping, handling and storage costs, and the total cost of administration of the vaccine, including the cost of supplies, data entry, vaccine counseling, inventory management and routine nursing activities based on the current year's medicare rates as published by the United States centers for medicare and medicaid services.
§ 2. Clause (ii) of subparagraph (E) of paragraph 17 of subsection (i) of section 3216 of the insurance law, as amended by chapter 219 of the laws of 2011, is amended to read as follows:
(ii) immunizations that have in effect a recommendation from the advisory committee on immunization practices of the centers for disease control and prevention with respect to the individual involved, including reimbursement to the health care provider for the acquisition costs
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD07666-01-3
of the vaccine, according to the current or most recently reported United States centers for disease control and prevention private sector cost plus a minimum of twenty-one percent for shipping, handling and storage costs, and the total cost of administration of the vaccine, including the cost of supplies, data entry, vaccine counseling, inventory management and routine nursing activities based on the current year's medicare rates as published by the United States centers for medicare and medicaid services;
§ 3. Clause (iii) of subparagraph (B) of paragraph 8 of subsection (l) of section 3221 of the insurance law, as amended by chapter 219 of the laws of 2011, is amended to read as follows:
(iii) necessary immunizations, as determined by the superintendent in consultation with the commissioner of health, consisting of at least adequate dosages of vaccine against diphtheria, pertussis, tetanus, polio, measles, rubella, mumps, haemophilus influenzae type b and hepatitis b, which meet the standards approved by the United States public health service for such biological products, including reimbursement to the health care provider for the acquisition costs of the vaccine, according to the current or most recently reported United States centers for disease control and prevention private sector cost plus a minimum of twenty-one percent for shipping, handling and storage costs, and the total cost of administration of the vaccine, including the cost of supplies, data entry, vaccine counseling, inventory management and routine nursing activities based on the current year's medicare rates as published by the United States centers for medicare and medicaid services.
§ 4. Clause (ii) of subparagraph (E) of paragraph 8 of subdivision (l) of section 3221 of the insurance law, as amended by chapter 219 of the laws of 2011, is amended to read as follows:
(ii) immunizations that have in effect a recommendation from the advisory committee on immunization practices of the centers for disease control and prevention with respect to the individual involved, including reimbursement to the health care provider for the acquisition costs of the vaccine, according to the current or most recently reported United States centers for disease control and prevention private sector cost plus a minimum of twenty-one percent for shipping, handling and storage costs, and the total cost of administration of the vaccine, including the cost of supplies, data entry, vaccine counseling, inventory management and routine nursing activities based on the current year's medicare rates as published by the United States centers for medicare and medicaid services;
§ 5. Subparagraph (C) of paragraph 2 of subsection (j) of section 4303 of the insurance law, as amended by chapter 219 of the laws of 2011, is amended to read as follows:
(C) necessary immunizations, as determined by the superintendent in consultation with the commissioner of health, consisting of at least adequate dosages of vaccine against diphtheria, pertussis, tetanus, polio, measles, rubella, mumps, haemophilus influenzae type b and hepatitis b, which meet the standards approved by the United States public health service for such biological products, including reimbursement to the health care provider for the acquisition costs of the vaccine, according to the current or most recently reported United States centers for disease control and prevention private sector cost plus a minimum of twenty-one percent for shipping, handling and storage costs, and the total cost of administration of the vaccine, including the cost of supplies, data entry, vaccine counseling, inventory management and routine nursing activities based on the current year's medicare rates as published by the United States centers for medicare and medicaid services.
§ 6. Subparagraph (B) of paragraph 3 of subsection (j) of section 4303 of the insurance law, as added by chapter 219 of the laws of 2011, is amended to read as follows:
(B) immunizations that have in effect a recommendation from the advisory committee on immunization practices of the centers for disease control and prevention with respect to the individual involved, including reimbursement to the health care provider for the acquisition costs of the vaccine, according to the current or most recently reported United States centers for disease control and prevention private sector cost plus a minimum of twenty-one percent for shipping, handling and storage costs, and the total cost of administration of the vaccine, including the cost of supplies, data entry, vaccine counseling, inventory management and routine nursing activities based on the current year's medicare rates as published by the United States centers for medicare and medicaid services;
§ 7. This act shall take effect on the first of January after it shall have become a law and shall apply to any contract entered into, delivered, amended or modified on or after the date it takes effect.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the insurance law, in relation to insurance reimburse- ment for vaccination
Purpose or general idea of bill
To require insurance companies to reimburse healthcare providers for the full cost of vaccination.
Summary of specific provisions
Section one of the bill amends clause (iii) of subparagraph (B) of para- graph 17 of subsection (i) of § 3216 insurance law to include reimburse- ment to health care providers for the acquisition costs of the vaccine, according to the current or most recently reported United States centers for disease control and prevention private sector cost plus a minimum of twenty-one percent for shipping, handling and storage costs, and the total cost of administration of the vaccine, including the cost of supplies, data entry, vaccine counseling, inventory management and routine nursing activities based on the current year's Medicare rates as published by the United States Centers for Medicare and Medicaid Services.
Section two of the bill provides effective date.
Justification
Vaccines are among the top overhead expenses for pediatricians and pediatric nurse practitioners. It is important that insurers cover the total direct and indirect practice expenses, including a margin for the vaccine product and office costs, and the time spent counseling families on the indications and potential side effects of a vaccine. The bill is keyed primarily to prices and rates recognized by the federal Centers for Disease Control and Medicare.
One of the goals of the American Academy of Pediatrics; other healthcare professional organizations; and local, state, and federal public health agencies is to promote maximum immunization for infants, children, adolescents, young adults, and older adults. To achieve this goal, healthcare providers should be paid for the full cost of the vaccine and vaccine-related expenses.
Prior legislative history
Senate:
New Bill
Assembly:
2021-2022: A227 - referred to Insurance committee
2019-2020: A1158 - referred to Insurance committee
2017-18: A4061 - referred to Insurance committee 2015-16: A3356 - referred to Insurance committee
2013-14: A7248 - referred to Insurance committee
Fiscal implications
None.
Effective date
The first day of January after it shall have become a law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.